Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids

Condition(s) studied

Investigational drug(s) / intervention(s)

TU-LESS: TU-LESS group will receive TU-LESS for myomectomy; MPLS group will receive MPLS for myomectomy

MPLS: Patients with uterine who plan to receive MPLS for myomectomy

Study summary

Myomectomy was preferably applied in females with reproductive requirements, which could be achieved by transumbilical laparoendoscopic single-site surgery (TU-LESS) or multi-port laparoscopic surgery (MPLS). Power morcellation used in MPLS was correlated with unidentified risk of tumor dissemination, especially in cases with accidental surgical findings of uterine sarcoma or leiomyosarcoma. Moreover, TU-LESS was reported to exceed MPLS in fast recovery. Therefore, the aim of this prospective cohort study is to compare the effectiveness of fast recovery and relative risk of tumor dissemination between TU-LESS and MPLS in myomectomy for the treatment of uterine fibroids.

Eligibility

Primary outcome measure(s)

• Duration of hospital stay after surgery — From enrollment to 1 month after receiving myomectomy
  The number of days between myomectomy and the day of hospital discharge.

Trial sites (1)

More West China Second University Hospital trials in China

Other trials for the same condition